• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β受体阻滞剂在危重症患者中的免疫调节和自主神经调控作用:文献复习。

Beta-Blockers as an Immunologic and Autonomic Manipulator in Critically Ill Patients: A Review of the Recent Literature.

机构信息

Emergency Medicine, Freeman Health System, Joplin, MO 64804, USA.

Medical Education Department, Kansas City University, Kansas City, MO 64106, USA.

出版信息

Int J Mol Sci. 2024 Jul 24;25(15):8058. doi: 10.3390/ijms25158058.

DOI:10.3390/ijms25158058
PMID:39125627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11311757/
Abstract

The autonomic nervous system plays a key role in maintaining body hemostasis through both the sympathetic and parasympathetic nervous systems. Sympathetic overstimulation as a reflex to multiple pathologies, such as septic shock, brain injury, cardiogenic shock, and cardiac arrest, could be harmful and lead to autonomic and immunologic dysfunction. The continuous stimulation of the beta receptors on immune cells has an inhibitory effect on these cells and may lead to immunologic dysfunction through enhancing the production of anti-inflammatory cytokines, such as interleukin-10 (IL-10), and inhibiting the production of pro-inflammatory factors, such as interleukin-1B IL-1B and tissue necrotizing factor-alpha (TNF-alpha). Sympathetic overstimulation-induced autonomic dysfunction may also happen due to adrenergic receptor insensitivity or downregulation. Administering anti-adrenergic medication, such as beta-blockers, is a promising treatment to compensate against the undesired effects of adrenergic surge. Despite many misconceptions about beta-blockers, beta-blockers have shown a promising effect in decreasing mortality in patients with critical illness. In this review, we summarize the recently published articles that have discussed using beta-blockers as a promising treatment to decrease mortality in critically ill patients, such as patients with septic shock, traumatic brain injury, cardiogenic shock, acute decompensated heart failure, and electrical storm. We also discuss the potential pathophysiology of beta-blockers in various types of critical illness. More clinical trials are encouraged to evaluate the safety and effectiveness of beta-blockers in improving mortality among critically ill patients.

摘要

自主神经系统通过交感神经系统和副交感神经系统在维持身体止血方面发挥着关键作用。作为对多种病理情况(如感染性休克、脑损伤、心源性休克和心脏骤停)的反射,交感神经过度刺激可能是有害的,并导致自主和免疫功能障碍。β 受体在免疫细胞上的持续刺激对这些细胞具有抑制作用,并可能通过增强抗炎细胞因子(如白细胞介素-10 (IL-10))的产生和抑制促炎因子(如白细胞介素-1B [IL-1B] 和组织坏死因子-α [TNF-α])的产生导致免疫功能障碍。交感神经过度刺激引起的自主神经功能障碍也可能由于肾上腺素能受体不敏感或下调而发生。给予抗肾上腺素能药物,如β受体阻滞剂,是一种有前途的治疗方法,可以补偿肾上腺素激增的不良影响。尽管人们对β受体阻滞剂存在许多误解,但β受体阻滞剂在降低危重病患者死亡率方面显示出了有希望的效果。在这篇综述中,我们总结了最近发表的讨论使用β受体阻滞剂作为降低危重病患者死亡率的有前途的治疗方法的文章,如感染性休克、创伤性脑损伤、心源性休克、急性失代偿性心力衰竭和电风暴患者。我们还讨论了β受体阻滞剂在各种类型的危重病中的潜在病理生理学。鼓励进行更多的临床试验来评估β受体阻滞剂在改善危重病患者死亡率方面的安全性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/11311757/5ed1f5b8f656/ijms-25-08058-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/11311757/a79ff04f356e/ijms-25-08058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/11311757/c2d69b306a0b/ijms-25-08058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/11311757/5ed1f5b8f656/ijms-25-08058-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/11311757/a79ff04f356e/ijms-25-08058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/11311757/c2d69b306a0b/ijms-25-08058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/11311757/5ed1f5b8f656/ijms-25-08058-g003.jpg

相似文献

1
Beta-Blockers as an Immunologic and Autonomic Manipulator in Critically Ill Patients: A Review of the Recent Literature.β受体阻滞剂在危重症患者中的免疫调节和自主神经调控作用:文献复习。
Int J Mol Sci. 2024 Jul 24;25(15):8058. doi: 10.3390/ijms25158058.
2
Is It Time to Beta Block the Septic Patient?是时候对脓毒症患者使用β受体阻滞剂了吗?
Biomed Res Int. 2015;2015:424308. doi: 10.1155/2015/424308. Epub 2015 Oct 18.
3
Hemodynamic response to β-blockers in severe sepsis and septic shock: A review of current literature.β-受体阻滞剂在严重脓毒症和脓毒性休克中的血流动力学反应:文献复习。
J Crit Care. 2019 Apr;50:138-143. doi: 10.1016/j.jcrc.2018.12.003. Epub 2018 Dec 5.
4
Beta-blockers in septic shock: a review.脓毒性休克中的β受体阻滞剂:综述
Rev Esp Anestesiol Reanim. 2015 Feb;62(2):90-5. doi: 10.1016/j.redar.2014.07.003. Epub 2014 Aug 22.
5
[Beta-blockers in Septic Shock].[脓毒性休克中的β受体阻滞剂]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2018 Nov;53(11-12):787-792. doi: 10.1055/s-0043-124906. Epub 2018 Nov 20.
6
Beta-blockers in intensive care medicine: potential benefit in acute brain injury and acute respiratory distress syndrome.重症医学中的β受体阻滞剂:对急性脑损伤和急性呼吸窘迫综合征的潜在益处。
Recent Pat Cardiovasc Drug Discov. 2012 Aug;7(2):141-51. doi: 10.2174/157489012801227274.
7
Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure.β受体阻滞剂对失代偿性心力衰竭患者心率自主调节及神经激素水平的影响
Ann Noninvasive Electrocardiol. 2001 Apr;6(2):98-106. doi: 10.1111/j.1542-474x.2001.tb00093.x.
8
[Autonomic dysfunction and beta-adrenergic blockers in multiple organ dysfunction syndrome].[多器官功能障碍综合征中的自主神经功能障碍与β-肾上腺素能阻滞剂]
Dtsch Med Wochenschr. 2008 Nov;133(48):2500-4. doi: 10.1055/s-0028-1100944. Epub 2008 Nov 19.
9
The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials.超短效β受体阻滞剂与血管升压药和正性肌力药在感染性休克重症患者中的联合使用:一项随机对照试验的系统评价和荟萃分析
Saudi Pharm J. 2024 Jun;32(6):102094. doi: 10.1016/j.jsps.2024.102094. Epub 2024 May 11.
10
The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review.脓毒性休克中的自主神经系统及其作为未来治疗靶点的作用:一篇叙述性综述。
Ann Intensive Care. 2021 May 17;11(1):80. doi: 10.1186/s13613-021-00869-7.

引用本文的文献

1
Beta blockers linked to reduced 1-Year mortality in critically ill congestive heart failure patients with differential benefits across subgroups.β受体阻滞剂与危重症充血性心力衰竭患者1年死亡率降低相关,且在不同亚组中有不同益处。
Sci Rep. 2025 Sep 2;15(1):32263. doi: 10.1038/s41598-025-17483-3.
2
Aggregate index of systemic inflammation as a novel prognostic biomarker in Chinese patients with acute decompensated heart failure: a population-based real-world study.全身炎症聚集指数作为中国急性失代偿性心力衰竭患者的一种新型预后生物标志物:一项基于人群的真实世界研究。
Front Endocrinol (Lausanne). 2025 Aug 13;16:1627821. doi: 10.3389/fendo.2025.1627821. eCollection 2025.
3

本文引用的文献

1
Cardiogenic shock without hypotension in acute severe primary mitral regurgitation: a case report.急性重度原发性二尖瓣反流伴无低血压的心源性休克:一例报告
Oxf Med Case Reports. 2024 May 20;2024(5):omae018. doi: 10.1093/omcr/omae018. eCollection 2024 May.
2
Favorable resuscitation characteristics in patients undergoing extracorporeal cardiopulmonary resuscitation: A secondary analysis of the INCEPTION-trial.接受体外心肺复苏患者的良好复苏特征:INCEPTION试验的二次分析
Resusc Plus. 2024 May 13;18:100657. doi: 10.1016/j.resplu.2024.100657. eCollection 2024 Jun.
3
Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI.
The Collapse of Brain Clearance: Glymphatic-Venous Failure, Aquaporin-4 Breakdown, and AI-Empowered Precision Neurotherapeutics in Intracranial Hypertension.
脑清除功能的崩溃:颅内高压中的淋巴-静脉功能衰竭、水通道蛋白4的破坏以及人工智能助力的精准神经治疗
Int J Mol Sci. 2025 Jul 25;26(15):7223. doi: 10.3390/ijms26157223.
4
Impact of β-blockers on mortality in critically Ill patients with type 2 myocardial infarction: insights from a retrospective cohort study.β受体阻滞剂对2型心肌梗死重症患者死亡率的影响:一项回顾性队列研究的见解
Front Cardiovasc Med. 2025 May 29;12:1531711. doi: 10.3389/fcvm.2025.1531711. eCollection 2025.
5
Hyperbaric oxygen therapy for paroxysmal sympathetic hyperactivity syndrome after brain injury: a multicenter, retrospective cohort study.高压氧治疗脑损伤后阵发性交感神经过度兴奋综合征:一项多中心回顾性队列研究
Med Gas Res. 2025 Jun 1;15(2):327-331. doi: 10.4103/mgr.MEDGASRES-D-24-00077. Epub 2024 Dec 7.
6
Complexities, Benefits, Risks, and Clinical Implications of Sodium Bicarbonate Administration in Critically Ill Patients: A State-of-the-Art Review.危重症患者使用碳酸氢钠的复杂性、益处、风险及临床意义:最新综述
J Clin Med. 2024 Dec 21;13(24):7822. doi: 10.3390/jcm13247822.
基于病因的心源性休克住院幸存者预后比较:急性心肌梗死(AMI)和非急性心肌梗死(Non-AMI)。
Ann Intensive Care. 2024 May 12;14(1):74. doi: 10.1186/s13613-024-01305-2.
4
Clinical impact of stellate ganglion phototherapy on ventricular tachycardia storm requiring mechanical circulatory support devices: a case report.星状神经节光疗对需要机械循环支持装置的室性心动过速风暴的临床影响:一例报告
Eur Heart J Case Rep. 2024 Apr 30;8(4):ytae177. doi: 10.1093/ehjcr/ytae177. eCollection 2024 Apr.
5
Stellate ganglion blockade for the management of ventricular arrhythmia storm.星状神经节阻滞用于治疗室性心律失常风暴。
Eur Heart J. 2024 Mar 7;45(10):834-836. doi: 10.1093/eurheartj/ehae083.
6
Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry.β受体阻滞剂早期用于心源性休克患者可改善预后:FRESHOCK多中心前瞻性注册研究分析
Pharmaceuticals (Basel). 2023 Dec 18;16(12):1740. doi: 10.3390/ph16121740.
7
Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion.急性心力衰竭伴射血分数降低患者的β受体阻滞剂管理:综述与专家共识意见
Front Cardiovasc Med. 2023 Nov 16;10:1263482. doi: 10.3389/fcvm.2023.1263482. eCollection 2023.
8
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.地佐辛和脓毒性休克患者的器官衰竭:STRESS-L 随机临床试验。
JAMA. 2023 Nov 7;330(17):1641-1652. doi: 10.1001/jama.2023.20134.
9
The role of beta-blocker drugs in critically ill patients: a SIAARTI expert consensus statement.β受体阻滞剂药物在重症患者中的作用:SIAARTI专家共识声明
J Anesth Analg Crit Care. 2023 Oct 23;3(1):41. doi: 10.1186/s44158-023-00126-2.
10
Dissecting Beta-Adrenergic Receptors: The Sum of Many Parts.剖析β-肾上腺素能受体:众多部分的总和
JACC Basic Transl Sci. 2023 Aug 28;8(8):989-991. doi: 10.1016/j.jacbts.2023.05.005. eCollection 2023 Aug.